Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | October 09, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 8ERQ | 8ERQ | SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324) | |
| 8H08 | P0DTC2 | SARS-CoV-2 BA.1 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H08 | 8H08 | SARS-CoV-2 BA.1 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H08 | P0DTC2 | SARS-CoV-2 BA.1 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H08 | 8H08 | SARS-CoV-2 BA.1 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8BH5 | 8BH5 | SARS-CoV-2 BA.2.12.1 RBD in complex with Beta-27 Fab and C1 nanobody | |
| 8BH5 | P0DTC2 | SARS-CoV-2 BA.2.12.1 RBD in complex with Beta-27 Fab and C1 nanobody | |
| 7YQT | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up) | |
| 7YQU | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down) | |
| 7YQW | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down) | |
| 7YR2 | Q9BYF1 | SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1) | |
| 7YR2 | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1) | |
| 7YR3 | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2) | |
| 7YR3 | Q9BYF1 | SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2) | |
| 7YR0 | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (interface) | |
| 7YR0 | 7YR0 | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (interface) | |
| 7YQX | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1) | |
| 7YQX | 7YQX | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1) | |
| 7YQY | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2) | |
| 7YQY | 7YQY | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2) | |
| 7YQZ | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3) | |
| 7YQZ | 7YQZ | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3) | |
| 7YR1 | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024 | |
| 7YR1 | 7YR1 | SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024 | |
| 8X5R | P0DTC2 | SARS-CoV-2 BA.2.75 Spike with K356T mutation (1 RBD up) | |
| 8X5Q | P0DTC2 | SARS-CoV-2 BA.2.75 Spike with K356T mutation (3 RBD down) | |
| 8H07 | P0DTC2 | SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H07 | 8H07 | SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H07 | P0DTC2 | SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H07 | 8H07 | SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8S9G | Q9BYF1 | SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8S9G | P0DTC2 | SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8S9G | 8S9G | SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8FXC | Q9BYF1 | SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8FXC | P0DTC2 | SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8FXC | 8FXC | SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8DF5 | 8DF5 | SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab | |
| 8DF5 | Q9BYF1 | SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab | |
| 8DF5 | P0DTC2 | SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab | |
| 7ZFC | 7ZFC | SARS-CoV-2 Beta RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs | |
| 7ZFC | P0DTC2 | SARS-CoV-2 Beta RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs | |
| 7YBM | P0DTC2 | SARS-CoV-2 C.1.2 variant spike (Close state) | |
| 7KDL | P0DTC2 | SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G) | Spike glycoprotein |
| 7KDJ | P0DTC2 | SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G) | Spike glycoprotein |
| 7KEC | P0DTC2 | SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification) | Spike glycoprotein |
| 7KEA | P0DTC2 | SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub classification) | Spike glycoprotein |
| 7KE9 | P0DTC2 | SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) | Spike glycoprotein |
| 7KEB | P0DTC2 | SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) | Spike glycoprotein |
| 7KDI | P0DTC2 | SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G) | Spike glycoprotein |
| 7KE4 | P0DTC2 | SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-class) | Spike glycoprotein |
